[1] Jansen KL. A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs. 2000 Oct-Dec; 32(4):419-33.
[2] DEA to control "Special K" for the first time. Disponível em http://www.usdoj.gov/dea/pubs/pressrel/pr071399.htm. (acedido em 06/05/09)
[3] Code of Federal Regulations. Disponível em http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_13.htm. (acedido em 06/05/09)
[4] Copeland J, Dillon P. The health and psycho-social consequences of ketamine use. 2005 Mar; 16(2):122-131
[5] Office of National Drug Control Policy - Street Terms: Drugs and the Drug Trade. Disponível em http://www.whitehousedrugpolicy.gov/streetTerms/ByType.asp?intTypeID=32 (acedido a 12/05/09)
[6] greater dallas council on alcohol & drug abuse: ketamine. Disponível em http://www.gdcada.org/statistics/ketamine.htm (acedido a 12/05/09)
[7] Hazardous Substances Data Bank. Disponível em http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~2Y8Niy:1 (acedido a 12/05/09)
[8] The Merck Index. Disponível em https://themerckindex.cambridgesoft.com/TheMerckIndex/default.asp?formgroup=basenp_form_group&dataaction=db&dbname=TheMerckIndex (acedido a 12/05/09)
[9] Copeland J, Dillon P. The health and psycho-social consequences of ketamine use. Int J Grug Policy 2005; 16: 122–131.
[10] Vollenweidera FX, Leendersb KL, Oyec I, Hella D, Angsta J. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharm 1997, 7: 25–38.
[11] Liu J, Ji X-Q, Zhu X-Z. Comparison of psychic emergence reactions after (±)-ketamine and (+)-ketamine in mice. Life Sci 2006, 78: 1839-44.
[12] Infarmed. Disponível em http://www.infarmed.pt/ (acedido a 12/05/09)
[13] Bhutta AT. Ketamine: A Controversial Drug for Neonates. Semin Perinatol 2007 Oct; 31(5): 303 ‐ 08.
[14] Katzung BG. Basic and Clinical Pharmacology. 10th ed. Singapore: McGraw-Hill; 2007. p. 395-411.
[15] Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 2002; 30(7): 853–58.
[16] Legranda T, Royb S, Monchauda C, Grondina C, Duval M, Jacqz-Aigraina E. Determination of ketamine and norketamine in plasma by micro-liquid chromatography–mass spectrometry. J Pharmaceut Biomed Anal 2008 Sep; 48(1): 171–76.
[17] European Monitoring Centre For Drugs And Drug Addiction. Report on the Risk Assessment of ketamine in the Framework of the Joint Action on New Synthetic Drugs. Lisbon: 2000.
[18] Green SM, Coté CJ. Ketamine and Neurotoxicity: Clinical Perspectives and Implications for Emergency Medicine. Ann Emerg Med 2008.
[19] Vutskits L, Gascon E, Potter G, Tassonyi E, Kiss JZ. Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture. Toxicol. 2007 (234): 216–226.
[20] Ke JJ, Chen HI, Jen CJ, Kuo YM, Cherng CG, Tsai YPN, et al. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine. Toxicology and Applied Pharmacology 2008 (227): 239–247.
[21] Hayashi H, Dikkes P, Soriano SG. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Ped. Anaes. 2002 (12): 770–774.
[22] Vutskits L, Gascon E, Tassonyi E, Kiss, JZ. Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicol. 2006 (91): 540–549.
[23] Ketamine - The Risks. Disponível em http://www.talktofrank.com/drugs.aspx?id=188#risks (acedido a 15/05/09)
Imagens:
Contexto psico-social
Rave: http://seducaoinsana.files.wordpress.com/2008/01/rave.jpg
colher cristais: http://en.wikipedia.org/wiki/File:Ketaminehydrochloride.jpg
Parada gay: http://www.pinknews.co.uk/images/prideflagmanc.jpg
Street names
Special K: http://www.tampabayrun.com/Assets/Sponsor+Logos/Special+K.jpg
Curiosidades
video "ketamine is for horses": http://current.com/items/89057053_ketamine-is-for-horses.htm
Mecanismo de acção
Sistema límbico: http://www.nlm.nih.gov/medlineplus/ency/images/ency/fullsize/19244.jpg
NMDAR: adaptado de http://www.sistemanervoso.com/pagina.php?secao=6&materia_id=78&materiaver=1
NMDAR(2): adaptado de Bhutta AT. Ketamine: A Controversial Drug for Neonates. Semin Perinatol 2007 Oct; 31(5): 303 ‐ 08.
Formulações em Portugal
ketalar : http://www.projectghb.org/ppt/RecognizingX_K_G%20Spanish_files/slide0118_image147.jpg
Usos terapêuticos
Anestesia: http://www.unimedaracatuba.com.br/guiamedico/dicas/anestesia/anestesia.gif
Analgesia: http://homensdopantano.files.wordpress.com/2009/02/pain-map.jpg
Efeitos agudos
Sistema cardiovascular: http://www.thewellingtoncardiacservices.com/images/TheHeart/200177291-001_4.jpg
Cérebro: http://infosol.files.wordpress.com/2008/06/cerebro.jpg
Efeitos psicológicos
http://th01.deviantart.com/fs8/300W/i/2005/299/a/d/Hallucination_by_OrangeHeretic.jpg
Reacções de emergência
Operação: http://www.ca12demaio.ufc.br/images/20070726024754emergencia_SP.jpg
Mortalidade
Reanimação: http://blogs.smh.com.au/inkslinger/archives/overdose.jpg
Tratamento de intoxicações
Ventilação mecânica: http://www.santacatarinaoxigenio.com.br/produtos/home_care/aspiradores/vacuo/venturi_gd.jpg
Carvão activado: http://www.bbifiltracao.com.br/outros/carvao_ativado_g.jpg